Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy [kdSdc1_scRNAseq]
Ontology highlight
ABSTRACT: Syndecan-1 inhibition promotes anti-tumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy [kdSdc1_scRNAseq]
PROVIDER: PRJNA964467 | ENA |
REPOSITORIES: ENA
ACCESS DATA